It is difficult to establish dose-response relationships for ACE inhibitors in patients with hyperternion or congestive heart failure. This has led to the widely held opinion that the effects of ACE inhibitors are hardly dose dependent. The purpose of this short discussion is to demonstrate that this class of compounds, as well as the more recent angiotemin II receptor antagonists, exhibit some very clear dose-response relationships when these are evaluated in normal volunteers based on the mechanisms for which they were designed. Characterization of these dose-response curves is important in order to use these drugs at their optimol dose and to obtain the maximal therapeutic benefi
AIM: To compare angiotensin II receptor blockade, angiotensin converting enzyme (ACE) inhibition and...
The new ACE inhibitor trandolapril was administered to normal volunteers at daily doses of 0.5, 2, a...
AIM: To compare angiotensin II receptor blockade, angiotensin converting enzyme (ACE) inhibition and...
It is difficult to establish dose-response relationships for ACE inhibitors in patients with hyperte...
It is difficult to establish dose-response relationships for ACE inhibitors in patients with hyperte...
This series of studies was designed to assess in normal volunteers the relationships between various...
The studies described in this thesis investigated the haemodynamic response to initiation of therapy...
The studies described in this thesis investigated the haemodynamic response to initiation of therapy...
Abstract The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important ...
This series of studies was designed to assess in normal volunteers the relationships between various...
Control of cardiovascular (CV) risk factors, particularly hypertension, is still unsatisfactory, res...
Control of cardiovascular (CV) risk factors, particularly hypertension, is still unsatisfactory, res...
AIMS: The performance of the experimental paradigm of angiotensin challenges with continuous non-inv...
A range of studies are described examining the responses to blockade of the renin angiotensin system...
AIMS: The performance of the experimental paradigm of angiotensin challenges with continuous non-inv...
AIM: To compare angiotensin II receptor blockade, angiotensin converting enzyme (ACE) inhibition and...
The new ACE inhibitor trandolapril was administered to normal volunteers at daily doses of 0.5, 2, a...
AIM: To compare angiotensin II receptor blockade, angiotensin converting enzyme (ACE) inhibition and...
It is difficult to establish dose-response relationships for ACE inhibitors in patients with hyperte...
It is difficult to establish dose-response relationships for ACE inhibitors in patients with hyperte...
This series of studies was designed to assess in normal volunteers the relationships between various...
The studies described in this thesis investigated the haemodynamic response to initiation of therapy...
The studies described in this thesis investigated the haemodynamic response to initiation of therapy...
Abstract The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important ...
This series of studies was designed to assess in normal volunteers the relationships between various...
Control of cardiovascular (CV) risk factors, particularly hypertension, is still unsatisfactory, res...
Control of cardiovascular (CV) risk factors, particularly hypertension, is still unsatisfactory, res...
AIMS: The performance of the experimental paradigm of angiotensin challenges with continuous non-inv...
A range of studies are described examining the responses to blockade of the renin angiotensin system...
AIMS: The performance of the experimental paradigm of angiotensin challenges with continuous non-inv...
AIM: To compare angiotensin II receptor blockade, angiotensin converting enzyme (ACE) inhibition and...
The new ACE inhibitor trandolapril was administered to normal volunteers at daily doses of 0.5, 2, a...
AIM: To compare angiotensin II receptor blockade, angiotensin converting enzyme (ACE) inhibition and...